Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

RenalGuard fluid delivery device inhibits CIN

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Boccalandro F, Sheikh S, Fahim T, Angirekula M, Amaram S, Burks J.Intravenous Sodium Bicarbonate Versus Sodium Chloride for the Prevention of Contrast - Induced Nephropathy in Elective Coronary and Peripheral Diagnostic and Interventional Procedures: A Ramdomized Study. 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics: abstr. 323, 21 Sep 2010. Available from: URL: http://www.tctconference.com

    2. 2.

      Bartorelli AL, Ferrari C, Trabattoni D, Teruzzi G, Marana I, Assanelli E, Gatto P, Marenzi G.Furosemide-Induced Diuresis with Matched Hydration Compared to Standard Hydration for Prevention of Contrast-Induced Nephropathy. The MYTHOS Trial. 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics: abstr. 332, 21 Sep 2010. Available from: URL: http://www.tctconference.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    RenalGuard fluid delivery device inhibits CIN. React. Wkly. 1326, 4 (2010). https://doi.org/10.2165/00128415-201013260-00008

    Download citation

    Keywords

    • Chronic Kidney Disease
    • Sodium Bicarbonate
    • Urine Output
    • Chronic Kidney Disease Patient
    • Major Adverse Cardiac Event